Helix Fund
9
1M
7
0.22
2
- Stages of investment
- Areas of investment
Summary
The company was established in North America in United States. The main office of represented VC is situated in the Chicago.
The real fund results show that this VC is 6 percentage points less often commits exit comparing to other companies. Deals in the range of 1 - 5 millions dollars are the general things for fund. This Helix Fund works on 0 percentage points less the average amount of lead investments comparing to the other organizations. The top amount of exits for fund were in 2017. The high activity for fund was in 2015. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 deals per year.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Life Science. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight MediBeacon, Euclises Pharmaceuticals, Arvegenix.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Helix Fund, startups are often financed by St. Louis Arch Angels, Missouri Technology Corporation, Cultivation Capital. The meaningful sponsors for the fund in investment in the same round are BioGenerator, Missouri Technology Corporation, Cultivation Capital. In the next rounds fund is usually obtained by Cultivation Capital, St. Louis Arch Angels, Missouri Technology Corporation.
Investments analytics
Analytics
- Total investments
- 9
- Lead investments
- 0
- Exits
- 2
- Follow on index
- 0.22
- Investments by industry
- Biotechnology (6)
- Health Care (5)
- Pharmaceutical (2)
- Recruiting (2)
- Brand Marketing (2) Show 17 more
- Investments by region
-
- United States (8)
- China (1)
- Peak activity year
- 2015
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 314M
- Group Appearance index
- 0.78
- Avg. company exit year
- 7
- Avg. multiplicator
- 7.32
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| SynerZ Medical | 24 Feb 2015 | Biotechnology, Health Care, Medical Device, Diabetes | Seed | 650K | United States, St Louis, Missouri |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.